We are live on
!
Find out more
VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
14 hedge funds and large institutions have $69.7M invested in Verona Pharma in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 14 → 14 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.09% less ownership
Funds ownership: 6.27% → 6.18% (-0.09%)
47% less capital invested
Capital invested by funds: $132M → $69.7M (-$61.9M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
14
Holders Change
–
Holders Change %
0%
% of All Funds
0.32%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
1
Increased
1
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$80.1K |
| 2 |
OSNBOA
Old Second National Bank of Aurora
Aurora,
Illinois
|
+$24.9K |
Top Sellers
| 1 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$1.05M |
| 2 |
PA
Perceptive Advisors
New York
|
-$569K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$14K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.62K |
| 5 |
Morgan Stanley
New York
|
-$3.36K |